Please Wait
Applying Filters...
menu
    • menu
    Seqens is an integrated global leader in pharmaceutical solutions & specialty ingredients & provides custom-made solutions.

    Virtual Booth

    Contact Supplier

    AbbVie CDMO has been working with global companies to develop, manufacture & scale biopharmaceutical products.

    Virtual Booth

    Contact Supplier

    xyz-pharma-m-2024-10-07

    Virtual Booth

    Contact Supplier

    EUROAPI, the leading small molecules API player, provides both API sales & CDMO services.

    Virtual Booth

    Contact Supplier

    ChemWerth works in generic API development & supply, non-infringement patent strategy development and regulatory support.

    Virtual Booth

    Contact Supplier

    xyz-pharma-m-2024-10-07

    Virtual Booth

    Contact Supplier

    Menu

    Diphenylpyraline

    ACTIVE PHARMA INGREDIENTS

    INTERMEDIATES

    FINISHED DOSAGE FORMULATIONS

    DIGITAL CONTENT

    GLOBAL SALES INFORMATION

    PharmaCompass
    $ API Ref.Price (USD/KG) : 38Xls

    Filters

    clear-filterReset all filters
    Left Arrow
    Right Arrow

    Digital Content read-more

    Create Content with PharmaCompass, ask us

    NEWS #PharmaBuzz

    read-more
    read-more
    AbbVie makes a hefty play to boost aesthetics business, paying $550M
    AbbVie makes a hefty play to boost aesthetics business, paying $550M

    10 May 2021

    // K. Blankenship ENDPTS

    https://endpts.com/abbvie-makes-a-hefty-play-to-boost-aesthetics-business-paying-550m-for-non-invasive-body-sculpting-device/

    K. Blankenship ENDPTS
    10 May 2021
    Share Share
    Facing $50B Trial, Drugmakers Minimize Roles In Opioid Sales
    Facing $50B Trial, Drugmakers Minimize Roles In Opioid Sales

    21 Apr 2021

    // LAW360

    https://www.law360.com/lifesciences/articles/1377104

    LAW360
    21 Apr 2021
    Share Share
    AbbVie may face fewer wrinkles after judge suggests a 10Y ban on a Botox rival
    AbbVie may face fewer wrinkles after judge suggests a 10Y ban on a Botox rival

    09 Jul 2020

    // Ed Silverman STATNEWS

    https://www.statnews.com/pharmalot/2020/07/08/abbvie-allergan-botox-competition-itc/

    Ed Silverman STATNEWS
    09 Jul 2020
    Share Share
    Drug Cos. Say Foreign Status Outs Them From Opioid Case
    Drug Cos. Say Foreign Status Outs Them From Opioid Case

    21 Apr 2020

    // LAW360

    https://www.law360.com/lifesciences/articles/1265109/drug-cos-say-foreign-status-outs-them-from-opioid-case

    LAW360
    21 Apr 2020
    Share Share
    Korea bans local sales of Medytox’s BTX drug Meditoxin
    Korea bans local sales of Medytox’s BTX drug Meditoxin

    21 Apr 2020

    // By Kim Byung-wook KOREAHERALD

    http://www.koreaherald.com/view.php?ud=20200418000083

    By Kim Byung-wook KOREAHERALD
    21 Apr 2020
    Share Share
    Theravance Biopharma Announces Dosing of 1st Patient in Ph 2 Allergen Study
    Theravance Biopharma Announces Dosing of 1st Patient in Ph 2 Allergen Study

    03 Dec 2019

    // PR NEWSWIRE

    https://www.prnewswire.com/news-releases/theravance-biopharma-announces-dosing-of-first-patient-in-phase-2-allergen-challenge-study-of-td-8236-an-investigational-lung-selective-inhaled-pan-janus-kinase-jak-inhibitor-for-inflammatory-lung-diseases-300967785.html

    PR NEWSWIRE
    03 Dec 2019
    Share Share